Literature DB >> 19588647

Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.

Deepa Uchil1, D Pipalia, M Chawla, R Patel, Sonali Maniar, Archana Juneja.   

Abstract

AIMS: To study the prevalence of NAFLD in those patients attending the routine health checkup and to establish a relationship between NAFLD and metabolic syndrome. PATIENTS AND METHODS: All patients attending the health check-up had their blood pressure, height and weight, waist circumference measurements, blood sugars, lipid levels and ultrasound abdomen done. The prevalence of NAFLD among these subjects was determined and the presence of risk factors for metabolic disease in each individual was analysed. A relationship between NAFLD and metabolic syndrome was then established.
RESULTS: Of the 1003 people 225 (22.6%) had NAFLD with higher prevalence among males 164/565 (29%) than among females 61/438 (13.9%). In the NAFLD group normal body mass index (BMI) was present in only 49/225 (20%) of the subjects while 119/225 (52.8%) were overweight and 56/225 (24.8%) were obese. Though liver enzymes were normal the mean AST among cases was 37.41 +/- 14.50 and 33.93 +/- 14.15 among controls and the mean ALT was 38.74 +/- 17.96 among cases and 31.62 +/- 13.49 among controls. Prevalence of metabolic syndrome was 106/225 (47%) among cases and 179/778 (23%) among controls.
CONCLUSION: A diagnosis of fatty liver on ultrasound in an asymptomatic person should alert us of metabolic syndrome and its progression to cardiovascular disease. NAFLD may be considered as the hepatic component of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588647

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  23 in total

1.  Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Authors:  Maria Stepanova; Noreen Hossain; Arian Afendy; Kellie Perry; Zachary D Goodman; Ancha Baranova; Zobair Younossi
Journal:  Obes Surg       Date:  2010-01-30       Impact factor: 4.129

2.  Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.

Authors:  Shahinul Alam; Utpal Das Gupta; Mahbubul Alam; Jahangir Kabir; Ziaur Rahman Chowdhury; A K M Khorshed Alam
Journal:  Indian J Gastroenterol       Date:  2014-07-15

3.  Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?

Authors:  Mehmet Emre Atabek; Beray Selver Eklioglu; Nesibe Akyürek
Journal:  Eat Weight Disord       Date:  2014-05-21       Impact factor: 4.652

4.  Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.

Authors:  Jharna Puppala; Sukanya Bhrugumalla; Ajit Kumar; Siva Prasad Siddapuram; Prasad D K Viswa; Milind Kondawar; Jyothy Akka; Anjana Munshi
Journal:  Indian J Gastroenterol       Date:  2014-10-17

5.  Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors.

Authors:  Katherine T Brunner; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Michelle T Long
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-09       Impact factor: 11.382

6.  Combination drug treatment in patients with non-alcoholic fatty liver disease.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Hepatol       Date:  2010-04-27

7.  Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression.

Authors:  Walid E Zahran; Kholoud A Salah El-Dien; Philip G Kamel; Ahmed Shawky El-Sawaby
Journal:  Indian J Clin Biochem       Date:  2012-07-14

8.  Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes.

Authors:  Ya-ping Hao; Xiao-jing Ma; Yu-qi Luo; Jie Ni; Jian-xin Dou; Ya-qin Hu; Jia-an Zhu; Yu-qian Bao; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

9.  Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.

Authors:  Vishnubhotla Venkata Ravi Kanth; Mitnala Sasikala; Padaki Nagaraja Rao; Urmila Steffie Avanthi; Kalashikam Rajender Rao; Duvvuru Nageshwar Reddy
Journal:  World J Hepatol       Date:  2014-06-27

Review 10.  Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.

Authors:  Zaki A Sherif; Armana Saeed; Shima Ghavimi; Seyed-Mehdi Nouraie; Adeyinka O Laiyemo; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.